Omega Fund Management LLC Top Holdings
As of  03/31/2019

 12/31/2018 to 03/31/2019
Position Size
($ in 1000's)
Gossamer Bio 6,953,416 +6,953,416 $150,681
Replimune 5,103,455 UNCH $77,425
Translate Bio 2,437,603 UNCH $24,839
Paratek Pharmaceuticals 2,600,410 UNCH $13,938
ObsEva 999,364 UNCH $12,782
CymaBay Therapeutics 551,477 UNCH $7,324
FibroGen 130,646 UNCH $7,101
Cidara Therapeutics 1,508,794 UNCH $3,998
ESSA Pharma 1,084,848 UNCH $3,698
Jounce Therapeutics 529,965 UNCH $3,286
Pieris Pharmaceuticals 778,230 UNCH $2,607
Dicerna Pharmaceuticals 167,157 UNCH $2,449

See Full List: All Stocks Held By Omega Fund Management LLC
— Including:
     • Biggest new positions
     • Biggest exits
     • Biggest increased positions
     • Biggest decreased positions

See Details: Top 10 Stocks Held By Omega Fund Management LLC

Size ($ in 1000's)
At 03/31/2019: $311,888
At 12/31/2018: $134,874

Omega Fund Management LLC holdings changes, total fund size, and other information presented on was derived from Omega Fund Management LLC 13F filings. Link to 13F filings: SEC filings

Omega Fund Management LLC Top Holdings 13F Filings |

Copyright © 2013 - 2019, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.